Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery: correlation between oxaliplatin exposure and thrombocytopenia

Rate and extent of oxaliplatin absorption after hyperthermic intraperitoneal administration in peritoneal carcinomatosis patients

(2014) Carlos Pérez-Ruixo et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Neutrophil Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Oxaliplatin

(2013) Carlos Pérez-Ruixo et al.   CLINICAL PHARMACOKINETICS

Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: A French multicentre retrospective cohort study of 566 patients

(2013) N. Bakrin et al.   EJSO

Oxaliplatin-related thrombocytopenia

(2012) D. L. Jardim et al.   ANNALS OF ONCOLOGY

Population pharmacokinetics of hyperthermic intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis after cytoreductive surgery

(2012) Carlos Pérez-Ruixo et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case–control study on survival in patients with two year follow-up

(2012) Anna Fagotti et al.   GYNECOLOGIC ONCOLOGY

A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C

(2012) Konstantinos Votanopoulos et al.   JOURNAL OF SURGICAL RESEARCH

Current Status and Future Directions in the Treatment of Peritoneal Dissemination from Colorectal Carcinoma

(2012) Dominique Elias et al.   Surgical Oncology Clinics of North America

Pharmacokinetic and Pharmacodynamic Analysis of Hyperthermic Intraperitoneal Oxaliplatin-Induced Neutropenia in Subjects with Peritoneal Carcinomatosis

(2011) Belén Valenzuela et al.   AAPS Journal

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial

(2011) Xiao-Jun Yang et al.   ANNALS OF SURGICAL ONCOLOGY

Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study

(2011) B Royer et al.   BRITISH JOURNAL OF CANCER

Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy

(2010) Olivier Glehen et al.   CANCER

Population Pharmacokinetics and Pharmacodynamics of Cisplatinum During Hyperthermic Intraperitoneal Chemotherapy Using a Closed Abdominal Procedure

(2010) Eddy Cotte et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions

(2009) Radojka M. Savic et al.   AAPS Journal

A Systematic Review and Meta-Analysis of Cytoreductive Surgery with Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin

(2009) Christopher Cao et al.   ANNALS OF SURGICAL ONCOLOGY

Evaluation of different tests based on observations for external model evaluation of population analyses

(2009) Karl Brendel et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Cytoreductive Surgery and Intraoperative Hyperthermic Intraperitoneal Chemotherapy with Paclitaxel: A Clinical and Pharmacokinetic Study

(2008) Eelco de Bree et al.   ANNALS OF SURGICAL ONCOLOGY

Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R

(2008) Emmanuelle Comets et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion

(2008) H. Mahteme et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY